On December 30, 2022, Pluristem Therapeutics, Inc closed the transaction. The company amended the terms of the transaction. The company has received $8,469,323 pursuant to exemption provided under Regulation D form 14 investors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.89 USD | +5.18% | +5.18% | +27.05% |
02/05 | Pluri Inc. Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment | CI |
02/05 | Pluri Inc. Announces Appointments to Its Scientific Advisory Board | CI |
1st Jan change | Capi. | |
---|---|---|
+27.05% | 30.18M | |
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |
- Stock Market
- Equities
- PLUR Stock
- News Pluri Inc.
- Pluri Inc. announced that it has received $8.469323 million in funding